Skye Bioscience, Inc. Prepaid Expense, Current
Skye Bioscience, Inc. (SKYE) had Prepaid Expense, Current of $415.16 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current › Prepaid Expense, Current
us-gaap:PrepaidExpenseCurrent · last filed 2026-08-14
- 2026-06-30: Prepaid Expense, Current $415.16K.
- 2026-03-31: Prepaid Expense, Current $1.22M.
- 2025-12-31: Prepaid Expense, Current $504.89K.
- 2025-09-30: Prepaid Expense, Current $3.71M.
| Period end | Prepaid Expense, Current | Prepaid Expense, Current as first filed |
|---|---|---|
| 2026-06-30 | $415.16K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $1.22M 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $504.89K 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $3.71M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $1.26M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $575.38K 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $201.96K 10-K · filed 2026-03-10 | |
| 2024-09-30 | $664.60K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $1.10M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $640.54K 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $194.26K 10-K · filed 2025-03-20 | $425.26K 10-K · filed 2024-03-22 |
| 2023-09-30 | $207.23K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $270.54K 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $957.59K 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $780.81K 10-K · filed 2024-03-22 | $850.38K 10-K · filed 2023-03-31 |
| 2022-09-30 | $708.48K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $871.43K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $822.54K 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $554.22K 10-K · filed 2023-03-31 | |
| 2020-12-31 | $190.13K 10-K · filed 2022-03-28 | |
| 2020-09-30 | $116.23K 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $114.25K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $99.07K 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $152.69K 10-K · filed 2021-03-02 | |
| 2019-09-30 | $395.44K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $262.27K 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $301.81K 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $93.19K 10-K · filed 2020-03-23 | |
| 2018-09-30 | $96.52K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $155.52K 10-Q · filed 2018-08-10 | |
| 2018-03-31 | $206.32K 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $291.43K 10-K · filed 2019-03-14 | |
| 2017-09-30 | $253.48K 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $292.49K 10-Q · filed 2017-08-11 | |
| 2017-03-31 | $151.16K 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $170.16K 10-K · filed 2018-03-19 | |
| 2016-09-30 | $249.19K 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $122.54K 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $157.10K 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $158.95K 10-K · filed 2017-03-10 | |
| 2015-09-30 | $95.55K 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $152.09K 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $222.28K 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $64.49K 10-K · filed 2016-03-21 | |
| 2014-01-31 | $13.98K 10-Q · filed 2014-03-17 | |
| 2013-10-31 | $15.59K 10-Q · filed 2014-09-15 | |
| 2013-07-31 | $3.81K 10-Q · filed 2013-09-16 | |
| 2013-04-30 | $3.11K 10-Q · filed 2013-06-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |